anisodamine has been researched along with interleukin-8 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gondaira, F; Kojio, S; Ohmura, M; Ou, ZL; Yamamoto, T; Zhang, HM | 1 |
Ou, ZL; Yamamoto, T; Zhang, HM | 1 |
2 other study(ies) available for anisodamine and interleukin-8
Article | Year |
---|---|
Protective effect of anisodamine against Shiga toxin-1: inhibition of cytokine production and increase in the survival of mice.
Topics: Animals; Cell Line; Cell Survival; Cytokines; Dinoprostone; Escherichia coli Infections; Gene Expression; Humans; Injections, Intraperitoneal; Interleukin-1; Interleukin-8; Male; Mice; Mice, Inbred C57BL; Monocytes; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Shiga Toxin 1; Solanaceous Alkaloids; Survival Rate; Tumor Necrosis Factor-alpha | 2001 |
Anisodamine inhibits shiga toxin type 2-mediated tumor necrosis factor-alpha production in vitro and in vivo.
Topics: Animals; Cell Line; Cell Survival; Cells, Cultured; Dinoprostone; Drugs, Chinese Herbal; Gene Expression; Humans; Interleukin-1; Interleukin-10; Interleukin-8; Mice; Mice, Inbred C57BL; Monocytes; Shiga Toxin 2; Solanaceous Alkaloids; Tumor Necrosis Factor-alpha | 2001 |